NCT04329793

Brief Summary

The improvement of walking capacity is a key objective of the rehabilitation of children with PC. There are different approaches from physiotherapy to address this need, including walking on the ground and on treadmill with partial weight support. Currently, there are robotic technologies adapted to the functional rehabilitation of patients. Assisted gait training with robotic devices such as the Walkbot allows a longer duration of training, at more variable speeds, and with a constant gait pattern adapted to the patient. This training, based on the intensity and repetition of the movement, has beneficial effects on the recovery and improvement of the patient's postural and locomotor functions. There are some studies that evaluate walking interventions on treadmill with partial weight support, on the ground and in assisted walking robot in patients with PC. Currently, there are no studies conducted that report the effectiveness of interventions performed with robotic walking training device Walkbot K on PC. However, studies in adults with Walkbot S, affected with neurological injury, have reported good results. Assisted gait training with robotic devices such as the Walkbot, based on the intensity and repetition of the movement, has beneficial effects on the recovery and improvement of the patient's postural and locomotor functions. However, due to the little evidence that exists, it is necessary to know the effectiveness of the Walkbot assisted walking robot in these patients by means of a clinical trial that allows to firmly establish the scope of its benefits.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
23

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Apr 2019

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 8, 2019

Completed
11 months until next milestone

First Submitted

Initial submission to the registry

March 7, 2020

Completed
25 days until next milestone

First Posted

Study publicly available on registry

April 1, 2020

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 14, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 14, 2021

Completed
Last Updated

May 4, 2021

Status Verified

May 1, 2021

Enrollment Period

1.9 years

First QC Date

March 7, 2020

Last Update Submit

May 2, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • Ability and quality of walking.

    Changes in Gross Motor Function Measure-88 (dimensions IV y V)

    Baseline, immediately after the intervention, 1 month after the intervention, 3 months after the intervention

Secondary Outcomes (6)

  • Functionality and autonomy

    Baseline, immediately after the intervention, 1 month after the intervention, 3 months after the intervention

  • Muscle strength

    Baseline, immediately after the intervention, 1 month after the intervention, 3 months after the intervention

  • Range of motion

    Baseline, immediately after the intervention, 1 month after the intervention, 3 months after the intervention

  • Spasticity

    Baseline, immediately after the intervention, 1 month after the intervention, 3 months after the intervention

  • Quality of walking: Edinburgh Visual Gait Scale

    Baseline, immediately after the intervention, 1 month after the intervention, 3 months after the intervention

  • +1 more secondary outcomes

Study Arms (2)

Intervention arm

EXPERIMENTAL

Assisted gait training with Walkbot System and their usual Physical Therapy.

Device: Assisted gait training with Walkbot SystemOther: Physical Therapy

Control arm

ACTIVE COMPARATOR

Their usual Physical Therapy.

Other: Physical Therapy

Interventions

The experimental group will receive at least 3 treatment sessions per week consisting of 40 minutes in robot-assisted gait training with Walkbot System in addition to their usual Physical therapy sessions. In total, the number of Walkbot sessions will be 20, in uninterrupted weeks.

Also known as: Physical Therapy
Intervention arm

The control group will receive their usual Physical therapy sessions during 6 weeks.

Control armIntervention arm

Eligibility Criteria

Age3 Years - 17 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Cerebral palsy diagnosis (diplegia or tetraplegia)
  • Ability to communicate even if not verbal (yes/not; gestures; pictograms; sounds)
  • Levels II, III and IV in GMFCS
  • Unsupported seating capacity
  • Go on standing with or without help
  • Not receiving therapy with a walking robot and not having received it in at least one year

You may not qualify if:

  • Serious psychiatric problems
  • Serious heart problems
  • Active tumors
  • Severe joint degenerative problems
  • Degenerative diseases of the nervous system
  • Mitochondrial diseases
  • Recent surgeries
  • Unbound fractures
  • Severe osteoporosis
  • Uncontrolled seizures
  • Open wounds in the lower half of the body
  • Extreme fear of being placed in robotic devices
  • Anthropomorphic measures are below the minimum required to use the device

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Raquel Olmos Gómez

Yecla, Murcia, 30510, Spain

Location

Related Publications (1)

  • Olmos-Gomez R, Calvo-Munoz I, Gomez-Conesa A. Treatment with robot-assisted gait trainer Walkbot along with physiotherapy vs. isolated physiotherapy in children and adolescents with cerebral palsy. Experimental study. BMC Neurol. 2024 Jul 15;24(1):245. doi: 10.1186/s12883-024-03750-9.

MeSH Terms

Conditions

Cerebral Palsy

Interventions

Physical Therapy Modalities

Condition Hierarchy (Ancestors)

Brain Damage, ChronicBrain DiseasesCentral Nervous System DiseasesNervous System Diseases

Intervention Hierarchy (Ancestors)

TherapeuticsRehabilitation

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal investigator

Study Record Dates

First Submitted

March 7, 2020

First Posted

April 1, 2020

Study Start

April 8, 2019

Primary Completion

March 14, 2021

Study Completion

March 14, 2021

Last Updated

May 4, 2021

Record last verified: 2021-05

Locations